External Partners

We are committed to accessing cutting edge research and creativity wherever it takes place, be it in leading academic laboratories or small biotechnology companies.  Collaborations with external partners are key to our success. We recognize that achievements are not reached alone; they are the result of teamwork.  Boehringer Ingelheim supports joint and independent research at leading universities and research institutions, and develops partnerships with experts in industry. This approach has the potential to accelerate the successful discovery and development of innovative new medicines.
 

Licensing and Partnerships

Boehringer Ingelheim (Canada) Ltd./Ltée. ensures access to new technologies and rewards innovators through development of partnerships and acquisition of specific technology licenses from universities and industry.  Such partnerships are key to our goal of bringing new and effective treatments to the market.

There are many opportunities for collaborative projects and partnerships with academia and industrial partners offering expertise, novel technologies and methods, screening capabilities, or compounds, that complement our internal research programs. The highest priority areas are in infectious diseases including virology and anti-bacterials.